XML 28 R16.htm IDEA: XBRL DOCUMENT v3.25.2
Segment and Geographical Data
 9 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Segment and Geographical Data
Note 8 — Segment and Geographical Data
Operating segments are identified as components of an enterprise in which discrete financial information is available for evaluation by the chief operating decision-maker (“CODM”) in making decisions regarding assessing business performance and allocating resources and capital. Management has concluded that the Company operates in one segment based upon the information used by the CODM in evaluating the performance of the Company’s business and allocating resources and capital.
Disaggregation of Revenues
The Company has distribution agreements with regional or national distributors (including wholesalers and medical suppliers) to ensure broad availability of its products as well as a direct sales force in certain countries and regions around the world. In the United States and Canada, the Company utilizes its key account managers that call on payers, retailers, wholesalers and institutional customers, and field-based territory managers that call on health care providers and pharmacies. In certain markets within Europe, the Company has dedicated sales representatives and in certain regions of the Middle East and Africa, the Company has distribution agreements. In Asia, the Company has distribution agreements, and in China the Company relies on its own commercial team to support sales execution. In Latin America, the Company maintains distribution agreements and direct sales representatives.
The Company disaggregates its revenue by geography and product line as management believes these categories best depict how the nature, amount, and timing of revenues and cash flows are affected by economic factors.
Revenues by geographic region are as follows:
 Three months ended June 30,Nine months ended June 30,
2025202420252024
United States$160.2 $143.6 $437.1 $439.8 
International(1)
135.3 128.9 379.3 397.2
Total$295.5 $272.5 $816.4 $837.0 
(1)For the three and nine months ended June 30, 2025 and 2024, no individual country outside of the United States generated net revenues that represented more than 10.0% of total revenues.
Revenues by product line are as follows:
 Three months ended June 30,Nine months ended June 30,
2025202420252024
Pen Needles$216.9 $201.3 $596.3 $629.3 
Syringes35.1 31.7 92.3 92.5 
Safety34.8 32.4 103.2 96.5 
Other(2)
3.2 3.5 9.9 10.6 
Contract Manufacturing5.5 3.6 14.7 8.1 
Total$295.5 $272.5 $816.4 $837.0 
(2)Other includes product sales for swabs and other accessories.